Form 4: CareDx Director Arthur Torres Receives 12,103 Restricted Stock Units

CareDx, Inc. Director Arthur Torres was granted 12,103 restricted stock units as part of his compensation, which are set to vest in 2026 or earlier.

Summary

• Arthur A. Torres, a Director of CareDx, Inc. (CDNA), acquired 12,103 shares of common stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this acquisition was June 13, 2025.
• These RSUs were granted at a price of $0 per unit, indicating they are a form of compensation.
• Following this transaction, Arthur A. Torres beneficially owns a total of 49,235 shares of CareDx, Inc. common stock.
• The 12,103 restricted stock units are scheduled to vest in a single installment on the earlier of (i) June 13, 2026, or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is generally a positive signal, indicating continued alignment of management interests with shareholders and a standard practice for incentivizing leadership. The potential for minor dilution is a common trade-off.

Positives

• The grant of restricted stock units to a director aligns the director's interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a standard form of equity compensation for directors, indicating ongoing commitment and incentivization.

Negatives

• The vesting of these restricted stock units will result in a slight dilution of existing shareholders' equity, as new shares will be issued upon vesting.

Risks

• Potential future dilution of existing shareholder value upon the vesting and issuance of the 12,103 restricted stock units.

Future Outlook

The 12,103 restricted stock units granted to Director Arthur A. Torres are scheduled to vest in one installment on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025, indicating a future increase in his direct beneficial ownership.

Corporate Governance

Related Party Transactions

• The acquisition of 12,103 Restricted Stock Units by Director Arthur A. Torres from CareDx, Inc. constitutes a related party transaction, as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon vesting of the RSUs, but also improved alignment of director interests with shareholder value.
• Employees: No direct impact mentioned, but reflects standard compensation practices for leadership.

Next Steps

• The 12,103 restricted stock units are expected to vest on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Key Dates

Keywords

CareDx, CDNA, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Equity Compensation, Arthur Torres, Beneficial Ownership